REFERENC
[1] Patlolla S.H., Schaff H.V., Nishimura R.A., et al. Incidence and
Burden of Tricuspid Regurgitation in Patients With Atrial Fibrillation
[J]. J Am Coll Cardiol, 2022, 80(24): 2289-98.
[2] Abe Y., Akamatsu K., Ito K., et al. Prevalence and Prognostic
Significance of Functional Mitral and Tricuspid Regurgitation Despite
Preserved Left Ventricular Ejection Fraction in Atrial Fibrillation
Patients [J]. Circ J, 2018, 82(5): 1451-8.
[3] Offen S., Playford D., Strange G., et al. Adverse Prognostic
Impact of Even Mild or Moderate Tricuspid Regurgitation: Insights from
the National Echocardiography Database of Australia [J]. J Am Soc
Echocardiogr, 2022, 35(8): 810-7.
[4] Wang N., Fulcher J., Abeysuriya N., et al. Tricuspid
regurgitation is associated with increased mortality independent of
pulmonary pressures and right heart failure: a systematic review and
meta-analysis [J]. Eur Heart J, 2019, 40(5): 476-84.
[5] Soulat-Dufour L., Lang S., Addetia K., et al. Restoring Sinus
Rhythm Reverses Cardiac Remodeling and Reduces Valvular Regurgitation in
Patients With Atrial Fibrillation [J]. J Am Coll Cardiol, 2022,
79(10): 951-61.
[6] Marrouche N.F., Wazni O., Mcgann C., et al. Effect of MRI-Guided
Fibrosis Ablation vs Conventional Catheter Ablation on Atrial Arrhythmia
Recurrence in Patients With Persistent Atrial Fibrillation: The DECAAF
II Randomized Clinical Trial [J]. JAMA, 2022, 327(23): 2296-305.
[7] Kistler P.M., Chieng D., Sugumar H., et al. Effect of Catheter
Ablation Using Pulmonary Vein Isolation With vs Without Posterior Left
Atrial Wall Isolation on Atrial Arrhythmia Recurrence in Patients With
Persistent Atrial Fibrillation: The CAPLA Randomized Clinical Trial
[J]. JAMA, 2023, 329(2): 127-35.
[8] Baman J.R., Passman R.S. Atrial Fibrillation [J]. JAMA,
2021, 325(21): 2218.
[9] Jastrzebski M., Moskal P., Bednarek A., et al. His-bundle pacing
as a standard approach in patients with permanent atrial fibrillation
and bradycardia [J]. Pacing Clin Electrophysiol, 2018, 41(11):
1508-12.
[10] Clark D.M., Plumb V.J., Epstein A.E., et al. Hemodynamic
effects of an irregular sequence of ventricular cycle lengths during
atrial fibrillation [J]. J Am Coll Cardiol, 1997, 30(4): 1039-45.
[11] Addetia K., Harb S.C., Hahn R.T., et al. Cardiac Implantable
Electronic Device Lead-Induced Tricuspid Regurgitation [J]. JACC
Cardiovasc Imaging, 2019, 12(4): 622-36.
[12] Moore S.K.L., Chau K.H., Chaudhary S., et al. Leadless
pacemaker implantation: A feasible and reasonable option in
transcatheter heart valve replacement patients [J]. Pacing Clin
Electrophysiol, 2019, 42(5): 542-7.
[13] Beurskens N.E.G., Tjong F.V.Y., De Bruin-Bon R.H.A., et al.
Impact of Leadless Pacemaker Therapy on Cardiac and Atrioventricular
Valve Function Through 12 Months of Follow-Up [J]. Circ Arrhythm
Electrophysiol, 2019, 12(5): e007124.
[14] Arkles J.S., Epstein A.E. Leadless Pacemakers and the Tricuspid
Valve: Can You Believe It? Can This Be True? [J]. Circ Arrhythm
Electrophysiol, 2019, 12(5): e007375.
[15] Jastrzebski M., Kielbasa G., Cano O., et al. Left bundle branch
area pacing outcomes: the multicentre European MELOS study [J]. Eur
Heart J, 2022, 43(40): 4161-73.
[16] Vahanian A., Beyersdorf F., Praz F., et al. 2021 ESC/EACTS
Guidelines for the management of valvular heart disease [J]. Eur
Heart J, 2022, 43(7): 561-632.
[17] Glikson M., Nielsen J.C., Kronborg M.B., et al. 2021 ESC
Guidelines on cardiac pacing and cardiac resynchronization therapy
[J]. Eur Heart J, 2021, 42(35): 3427-520.
[18] Jiang Z., Chang Q., Wu Y., et al. Typical BBB morphology and
implantation depth of 3830 electrode predict QRS correction by left
bundle branch area pacing [J]. Pacing Clin Electrophysiol, 2020,
43(1): 110-7.
[19] Burri H., Jastrzebski M., Cano O., et al. EHRA clinical
consensus statement on conduction system pacing implantation: endorsed
by the Asia Pacific Heart Rhythm Society (APHRS), Canadian Heart Rhythm
Society (CHRS), and Latin American Heart Rhythm Society (LAHRS) [J].
Europace, 2023, 25(4): 1208-36.
[20] Hindricks G., Potpara T., Dagres N., et al. 2020 ESC Guidelines
for the diagnosis and management of atrial fibrillation developed in
collaboration with the European Association for Cardio-Thoracic Surgery
(EACTS): The Task Force for the diagnosis and management of atrial
fibrillation of the European Society of Cardiology (ESC) Developed with
the special contribution of the European Heart Rhythm Association (EHRA)
of the ESC [J]. Eur Heart J, 2021, 42(5): 373-498.
[21] Zoghbi W.A., Adams D., Bonow R.O., et al. Recommendations for
Noninvasive Evaluation of Native Valvular Regurgitation: A Report from
the American Society of Echocardiography Developed in Collaboration with
the Society for Cardiovascular Magnetic Resonance [J]. J Am Soc
Echocardiogr, 2017, 30(4): 303-71.
[22] Naito M., David D., Michelson E.L., et al. The hemodynamic
consequences of cardiac arrhythmias: evaluation of the relative roles of
abnormal atrioventricular sequencing, irregularity of ventricular rhythm
and atrial fibrillation in a canine model [J]. Am Heart J, 1983,
106(2): 284-91.
[23] Stojadinovic P., Deshraju A., Wichterle D., et al. The
hemodynamic effect of simulated atrial fibrillation on left ventricular
function [J]. J Cardiovasc Electrophysiol, 2022, 33(12): 2569-77.
[24] Klein F.J., Bell S., Runte K.E., et al. Heart rate-induced
modifications of concentric left ventricular hypertrophy: exploration of
a novel therapeutic concept [J]. Am J Physiol Heart Circ Physiol,
2016, 311(4): H1031-H9.
[25] Silverman D.N., Rambod M., Lustgarten D.L., et al. Heart
Rate-Induced Myocardial Ca(2+) Retention and Left Ventricular Volume
Loss in Patients With Heart Failure With Preserved Ejection Fraction
[J]. J Am Heart Assoc, 2020, 9(17): e017215.
[26] Wahlberg K., Arnold M.E., Lustgarten D., et al. Effects of a
Higher Heart Rate on Quality of Life and Functional Capacity in Patients
With Left Ventricular Diastolic Dysfunction [J]. Am J Cardiol, 2019,
124(7): 1069-75.
[27] Infeld M., Wahlberg K., Cicero J., et al. Effect of
Personalized Accelerated Pacing on Quality of Life, Physical Activity,
and Atrial Fibrillation in Patients With Preclinical and Overt Heart
Failure With Preserved Ejection Fraction: The myPACE Randomized Clinical
Trial [J]. JAMA Cardiol, 2023, 8(3): 213-21.
[28] Su L., Wang S., Wu S., et al. Long-Term Safety and Feasibility
of Left Bundle Branch Pacing in a Large Single-Center Study [J].
Circ Arrhythm Electrophysiol, 2021, 14(2): e009261.
[29] Li X., Zhu H., Fan X., et al. Tricuspid regurgitation outcomes
in left bundle branch area pacing and comparison with right ventricular
septal pacing [J]. Heart Rhythm, 2022, 19(7): 1202-3.
[30] Hu Q., You H., Chen K., et al. Distance between the
lead-implanted site and tricuspid valve annulus in patients with left
bundle branch pacing: Effects on postoperative tricuspid regurgitation
deterioration [J]. Heart Rhythm, 2023, 20(2): 217-23.
[31] Huang X., Lin M., Huang S., et al. Impact on right ventricular
performance in patients undergoing permanent pacemaker implantation:
Left bundle branch pacing versus right ventricular septum pacing
[J]. J Cardiovasc Electrophysiol, 2022, 33(12): 2614-24.
[32] Heckman L.I.B., Luermans J., Curila K., et al. Comparing
Ventricular Synchrony in Left Bundle Branch and Left Ventricular Septal
Pacing in Pacemaker Patients [J]. J Clin Med, 2021, 10(4).
Figure 1. Severity of functional tricuspid regurgitation (FTR) in total
patients (n=29) during follow up. * There was a significant difference
compared to the baseline.